Daily Archives: July 25, 2018

Hologic’s Global Access Initiative Increases Availability of Diagnostic Testing in Resource-Limited Countries

–Program focuses on infectious disease assays – including HIV – for countries where critical testing is needed most —

MARLBOROUGH, Massachusetts, July 25, 2018 /PRNewswire/ — Hologic, Inc. (NASDAQ: HOLX) announced today the launch of the new Hologic Global Access Initiative, in partnership with the Clinton Health Access Initiative (CHAI) and MedAccess (backed by the U.K. government), to increase affordable access to molecular testing for HIV, hepatitis B and C (HBV and HCV) and human papillomavirus (HPV) in nearly 50 nations around the world. These countries, primarily across Africa and Southeast Asia, make up 90 percent of the HIV disease burden globally.1

Unveiled at the 2018 International AIDS Conference in Amsterdam, the Hologic Global Access Initiative will offer a single, all-inclusive pricing structure with no upfront cost or capital expenditure, providing access to four crucial molecular diagnostic tests across all eligible countries. This offers resource-limited countries a new, cost-effective way to mitigate the burden of infectious diseases with increased testing supply and superior technology.

“As a global leader in diagnostics, Hologic has the responsibility and privilege to serve people in need by providing accessible testing, which is crucial for managing care and reducing the spread of infectious diseases,” said Tom West, president, Diagnostic Solutions Division at Hologic. “Through this initiative in partnership with the global public health community, we’re determined to make an even greater impact in countries with limited resources and help reduce the burden of global infectious diseases, especially HIV.”

The Hologic Global Access Initiative supports UNAIDS’ 90-90-90 goal, which states that by 2020, 90 percent of people living with HIV will know their status, 90 percent of people with diagnosed HIV infection will receive sustained antiretroviral therapy, and 90 percent of people receiving antiretroviral therapy will have viral suppression. It also supports the objectives of the Unitaid-chaired Integrated Diagnostics Consortium by optimizing the efficiency of overall lab systems, reducing instrument downtime, and minimizing stockouts and waste.

“This initiative will provide significant savings to our partners that are scaling up HIV viral load testing. It will also enable countries to increase routine screening for hepatitis C and HPV. Since effective treatments are available for these diseases, early detection will save lives,” said CHAI Vice President of Global Markets, Alan Staple.

The Value of the Aptima® Assays on the Panther® System
Expected to launch in August 2018, the program will expand access to Hologic’s Panther system, a market-leading, integrated platform that fully automates molecular testing with true sample-to-result automation, adaptable workflow options, and a consolidated testing menu. Designed to be modular and scalable, the Panther system can accommodate the needs of large, centralized labs and smaller, decentralized labs alike. The Panther system also offers the highest output per square meter of any comparable molecular diagnostic instrument – up to 320 results in 8 hours in less than one square meter of space.2,3

Qualified assays available on the Panther system include:

  • The Aptima® HIV-1 Quant Dx* assay to aid in the diagnosis, confirmation and clinical management of HIV-1 infection.
  • The Aptima® HCV Quant Dx assay to aid in the diagnosis, confirmation and clinical management of HCV infection.
  • The Aptima® HBV Quant assay to aid in the clinical management of HBV infection.
  • The Aptima® HPV assay to detect 14 high-risk HPV types that are associated with the development of cervical cancer.

Where coinfection is prevalent, Hologic’s suite of Aptima virology assays offers the opportunity to simultaneously run multiple assays from one patient’s blood sample, which improves productivity and accelerates results, ultimately enhancing patient care.

Hologic has a long-term legacy in the virology space, beginning two decades ago and spanning development of the first nucleic acid tests to screen the blood supply for HIV and HCV. In the early 2000s, Hologic’s portfolio evolved to include qualitative assays for HIV and HCV, and now also includes quantitative assays for HIV, HBV and HCV. Hologic also has a long-standing market leadership position in cervical cancer screening, including the Aptima HPV assay, which identifies high-risk HPV mRNA that is indicative of the HPV infections most likely to lead to cervical disease.4

About Hologic
Hologic, Inc. is an innovative medical technology company primarily focused on improving women’s health and well-being through early detection and treatment. For more information on Hologic, visit www.hologic.com.

Forward-Looking Statements
This press release may contain forward-looking information that involves risks and uncertainties, including statements about the Hologic Global Access Initiative and use of the included diagnostic products. There can be no assurance that this initiative or the use of the included diagnostic products will achieve the benefits described herein or that such benefits will be replicated in any particular manner with respect to an individual patient. The actual effect of the initiative and/or the use of the products can only be determined on a case-by-case basis depending on the particular circumstances and patient in question. In addition, there can be no assurance that the initiative and/or the included diagnostic products will be commercially successful or achieve any expected level of sales. Hologic expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any such statements presented herein to reflect any change in expectations or any change in events, conditions or circumstances on which any such statements are based.

Hologic, Aptima, Panther and The Science of Sure are trademarks and/or registered trademarks of Hologic, Inc. in the United States and/or other countries.

*Currently not available for diagnostic use in the United States.

Investor Contact:
Michael Watts
+1 858.410.8588

Media Contact:
Jane Mazur
+1 508.263.8764 (direct)
+1 585.355.5978 (mobile)


  1. WHO. Immunizations, vaccines and biologicals: HIV/AIDS. Accessed June 27, 2018. http://www.who.int/immunization/topics/hiv/en/index1.html.
  2. Hologic, Inc. Data on File.
  3. Ratnam S, et al. Workflow and maintenance characteristics of five automated laboratory instruments for the diagnosis of sexually transmitted infections. J Clin Microbiol. 2014;52(7); 2299-2304.
  4. Aptima HPV assay [package insert]. AW-12820-001, Rev. 001. San Diego, CA: Hologic, Inc.; 2015.

Photo – https://mma.prnewswire.com/media/721662/Hologic_CHAI_Social_Tile_1.jpg
Photo – https://mma.prnewswire.com/media/721663/Hologic_CHAI_Social_Tile_3.jpg
Photo – https://mma.prnewswire.com/media/721664/Hologic_CHAI_Social_Tile_2.jpg

Premier Job Mokgoro meets with board and management of Mmabana, 26 Jul

Invitation to Premier TJ Mokgoro’s walkabout at Mmabana Mahikeng

The North West Premier Professor TJ Mokgoro will on Thursday 26 July 2018 hold a meeting with the board and management of Mmabana.

Prior to the meeting Premier Mokgoro will have a walkabout with regard to viewing the damaged buildings and other properties as a result of the uprisings which seized Mahikeng in April 2018.

The media is invited to the walkabout and will be afforded an opportunity to interact with Premier Mokgoro at 08h00 at the Mmabana building in Mmabatho.

Source: Government of South Africa

North West Legislature hosts Nelson Mandela Legacy Fun Walk/Run, 26 Jul

On Thursday 26 July 2018, the North West Provincial Legislature will be hosting 6,7km Nelson Mandela Legacy Fun Walk/Run as part of promoting healthy living.

The fun run/walk will begin at 8h00 at the legislature parking to Mmabatho Palms and back to the Legislature. At 10h00, the staff together with Members of the Provincial Legislature and the community will be playing soccer and netball. As part of promoting wellness there will also be health screening stations where participants can test their High blood pressure, cholesterol and diabetes.

Source: Government of South Africa

President Cyril Ramaphosa leads South African government in hosting 10th BRICS, 25 to 27 Jul

President Cyril Ramaphosa will lead the South African government in hosting the 10th BRICS Summit that takes place at the Sandton Convention Centre, Johannesburg, from today, Wednesday 25 July 2018, to Friday, July 27.

This is the first occasion on which President Ramaphosa will host the Summit, following his election as President in February 2018.

Under the theme, BRICS in Africa: Collaboration for Inclusive Growth and Shared Prosperity in the Fourth Industrial Revolution, the Summit is expected to be attended by Heads of State and Government from Brazil, Russia, India and China.

BRICS is an association of five major emerging national economies, in which South Africa began participating in 2010. Cooperation among BRICS members spans formal diplomatic engagement between the national governments; engagement through government-affiliated institutions, such as state-owned entities and business councils, and civil society and people-to-people engagement.

The Summit is focused on the need to strengthen the relationship between BRICS and Africa. In this regard BRICS leaders will also interact with African leaders on how best to bring about inclusive growth and shared prosperity through heightened collaboration.

In this context, leaders of the Republics of Namibia, Gabon, Angola, Senegal, Uganda, Togo and Rwanda will participate in the BRICS-Africa Outreach session.

Invitations have also been extended to all South African Development Community (SADC) Heads of State and Government.

The President will also chair the BRICS plus initiative that includes Heads of State and Government of the Republics of Turkey, Argentina and Jamaica.

The Summit commences today with BRICS leaders attending the BRICS Business Forum. President Ramaphosa will also host the leaders in a welcome dinner and entertainment programme at Monte casino, Fourways, Johannesburg.

Tomorrow, Thursday 26 July 2018, President Ramaphosa will chair two meetings of BRICS leaders who will then embark on a special retreat.

The last day of the Summit will see President Ramaphosa chairing the BRICS Outreach programme with African leaders in attendance. The President will also chair the BRICS Plus interaction and engage in a number of bilateral meetings with BRICS leaders.

NB: Only accredited media are allowed to cover the Summit. Pooling arrangements will apply in some sessions.

Source: Government of South Africa

Minister Mildred Oliphant launches Youth Development Programme in Limpopo, 28 Jul

The Unemployment Insurance Fund (UIF) and Limpopo Economic Development Agency (LEDA) launch a Youth Development Programme for young entrepreneurs

The Minister of Labour Mildred Oliphant, Mr. Teboho Maruping – the UIF Commissioner and the MEC for the Department of Economic Development, Environment and Tourism Mr Seaparo Sekoati – will on Saturday, 28 July 2018 launch a Youth Development Programme that will train and incubate the youth around the Limpopo Province.

This multi-million Venture Creation Project will impart entrepreneurial and business skills to a set of about 800 youths in this province.

Source: Government of South Africa